Skip to main content
. 2021 Nov 8;196:105206. doi: 10.1016/j.antiviral.2021.105206

Table 3.

Characterization of selected six neutralization mAbs (purified mAbs).

rSP specific mAbs End point values (ELISA) Affinity (KD) Surrogate Virus Neutralization Test (sVNT) (% of positive control) (1 mg/mL) PRNT (1 mg/mL)
F459G1 19.5 ng/mL 0.188 96.1% PRNT50≥640; PRNT90 = 320
F461G8 156 ng/mL 8.06 96% PRNT50 = 320; PRNT90 = 80
F461G11 156 ng/mL 9.66 96.2% PRNT50≥640; PRNT90 = 320
F461G14 4.9 ng/mL 0.353 96% PRNT50≥640; PRNT90 = 320
F461G15 4.9 ng/mL 0.212 96% PRNT50≥640; PRNT90 = 320
F461G16 3.1 ng/mL 0.177 96.2% PRNT50≥640; PRNT90 = 160

rSP: recombinant spike protein.